Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients, and the company said it expects to seek regulatory approvals by the end of the year.

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were the same as those with the injectable obesity drugs.